Switching between P2Y12 antagonists - From bench to bedside.
Sign Up to like & getrecommendations! Published in 2019 at "Vascular pharmacology"
DOI: 10.1016/j.vph.2019.01.003
Abstract: Platelet P2Y12 receptors play a key role in platelet activation and thrombus formation. Accordingly, P2Y12 receptor antagonists are the cornerstone of secondary prevention of atherothrombotic events in patients undergoing percutaneous coronary intervention (PCI). The availability… read more here.
Keywords: p2y12 antagonists; antagonists bench; pharmacology; bench bedside ... See more keywords